The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005.

[1]  Jen-Hao Chen,et al.  Nodal dissection for patients with gastric cancer: a randomised controlled trial. , 2006, The Lancet. Oncology.

[2]  Joon-Oh Park,et al.  An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. , 2005, International journal of radiation oncology, biology, physics.

[3]  C. Velde,et al.  Low Maruyama Index Surgery for Gastric Cancer: Blinded Reanalysis of the Dutch D1-D2 Trial , 2005, World Journal of Surgery.

[4]  G. Mann,et al.  Adjuvant therapy in gastric cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Ychou,et al.  Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  C. Bokemeyer,et al.  Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  C. V. D. van de Velde,et al.  Optimal locoregional treatment in gastric cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  D. Cunningham,et al.  Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) , 2005 .

[9]  J. Macdonald.  Role of post‐operative chemoradiation in resected gastric cancer , 2005, Journal of surgical oncology.

[10]  Cornelis J H van de Velde,et al.  Validation of a nomogram for predicting disease‐specific survival after an R0 resection for gastric carcinoma , 2005, Cancer.

[11]  E. Wrońska,et al.  Endosonography versus helical computed tomography for locoregional staging of gastric cancer. , 2004, Endoscopy.

[12]  M. Kattan,et al.  Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[14]  Aller,et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. , 2002, The New England journal of medicine.

[15]  A. Maes,et al.  Whole-body PET with FDG for the diagnosis of recurrent gastric cancer , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  L. Gianni,et al.  Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  S. O'mahony,et al.  Endoscopic mucosal resection for early gastric cancer , 2001, Gut.

[18]  B. Glimelius,et al.  A systematic overview of chemotherapy effects in gastric cancer. , 2001, Acta oncologica.

[19]  P. Dupont,et al.  Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  S. Barni,et al.  Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  S. Hundahl,et al.  The National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy , 2000, Cancer.

[22]  C. Earle,et al.  Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. , 1999, European journal of cancer.

[23]  D. Gouma,et al.  Extended lymph-node dissection for gastric cancer. , 1999, The New England journal of medicine.

[24]  P. Fayers,et al.  Patient survival after D 1 and D 2 resections for gastric cancer: long-term results of the MRC randomized surgical trial , 1999, British Journal of Cancer.

[25]  M. Huguier,et al.  [Extended lymph-node dissection for gastric cancer]. , 1999, Chirurgie; memoires de l'Academie de chirurgie.

[26]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[27]  Richard A. Szucs,et al.  TNM Classification of Malignant Tumors. 5th ed , 1998 .

[28]  R. Miceli,et al.  Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. , 1997, Annals of surgery.

[29]  A. Encke,et al.  A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. , 1996, Annals of surgery.

[30]  H. Katai,et al.  Surgical treatment for gastric cancer: the Japanese approach. , 1996, Seminars in oncology.

[31]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.

[32]  A. Li,et al.  A Prospective Randomized Trial Comparing R1 Subtotal Gastrectomy with R3 Total Gastrectomy for Antral Cancer , 1994, Annals of surgery.

[33]  C. V. D. van de Velde,et al.  Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  F. Lacaine,et al.  Total Versus Subtotal Gastrectomy for Adenocarcinoma of the Gastric Antrum: A French Prospective Controlled Study , 1989, Annals of surgery.

[35]  D. Dent,et al.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma , 1988, The British journal of surgery.

[36]  Tanaki Kajitani,et al.  The general rules for the gastric cancer study in surgery and pathology , 1981, The Japanese journal of surgery.

[37]  I sabel Mortara,et al.  International Union against Cancer , 1938, Nature.